MTMR4
Basic information
Region (hg38): 17:58489529-58517905
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTMR4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 48 | 51 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 48 | 3 | 3 |
Variants in MTMR4
This is a list of pathogenic ClinVar variants found in the MTMR4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-58492593-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
17-58492898-T-C | not specified | Uncertain significance (Jan 31, 2024) | ||
17-58492916-C-T | not specified | Uncertain significance (May 25, 2022) | ||
17-58494951-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
17-58494984-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
17-58495011-C-T | not specified | Uncertain significance (Sep 29, 2022) | ||
17-58495012-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
17-58495020-C-T | not specified | Uncertain significance (May 16, 2023) | ||
17-58495063-G-T | not specified | Uncertain significance (Mar 25, 2024) | ||
17-58495103-T-A | Benign (Aug 15, 2018) | |||
17-58495106-A-C | not specified | Uncertain significance (Oct 18, 2021) | ||
17-58495156-C-T | not specified | Uncertain significance (Jun 12, 2023) | ||
17-58495173-A-T | not specified | Uncertain significance (Oct 20, 2023) | ||
17-58495245-C-T | not specified | Uncertain significance (May 31, 2023) | ||
17-58495252-A-G | not specified | Uncertain significance (May 26, 2024) | ||
17-58495314-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
17-58495384-C-A | not specified | Uncertain significance (Dec 22, 2023) | ||
17-58495454-C-G | not specified | Uncertain significance (Jul 11, 2023) | ||
17-58495482-A-C | not specified | Uncertain significance (Feb 16, 2023) | ||
17-58495488-A-G | not specified | Uncertain significance (Nov 10, 2022) | ||
17-58495491-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
17-58495629-G-A | not specified | Uncertain significance (May 07, 2024) | ||
17-58495645-G-A | not specified | Uncertain significance (Jul 14, 2023) | ||
17-58495665-A-G | not specified | Likely benign (Aug 10, 2021) | ||
17-58495683-G-A | not specified | Uncertain significance (Oct 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MTMR4 | protein_coding | protein_coding | ENST00000323456 | 18 | 28369 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000407 | 125737 | 0 | 11 | 125748 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.49 | 424 | 680 | 0.623 | 0.0000390 | 7877 |
Missense in Polyphen | 139 | 323.85 | 0.42921 | 3580 | ||
Synonymous | 0.730 | 246 | 261 | 0.943 | 0.0000145 | 2339 |
Loss of Function | 6.06 | 8 | 57.7 | 0.139 | 0.00000314 | 632 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000307 | 0.000307 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Dephosphorylates proteins phosphorylated on Ser, Thr, and Tyr residues and low molecular weight phosphatase substrate para-nitrophenylphosphate. Phosphorylates phosphatidylinositol 3,4,5-trisphosphate (PIP3). {ECO:0000269|PubMed:11302699}.;
- Pathway
- Inositol phosphate metabolism - Homo sapiens (human);Autophagy - animal - Homo sapiens (human);Phosphatidylinositol signaling system - Homo sapiens (human);Signal Transduction;Metabolism of lipids;Metabolism;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the late endosome membrane;PI Metabolism;Phospholipid metabolism;Signaling by TGF-beta Receptor Complex;Signaling by TGF-beta family members;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs
(Consensus)
Intolerance Scores
- loftool
- 0.0342
- rvis_EVS
- -0.55
- rvis_percentile_EVS
- 19.93
Haploinsufficiency Scores
- pHI
- 0.586
- hipred
- Y
- hipred_score
- 0.575
- ghis
- 0.559
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.926
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Mtmr4
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- protein dephosphorylation;phosphatidylinositol biosynthetic process;transforming growth factor beta receptor signaling pathway;response to denervation involved in regulation of muscle adaptation;negative regulation of transforming growth factor beta receptor signaling pathway;peptidyl-tyrosine dephosphorylation;regulation of phosphatidylinositol dephosphorylation
- Cellular component
- extracellular space;endosome;cytosol;early endosome membrane
- Molecular function
- phosphatidylinositol-3-phosphatase activity;protein serine/threonine phosphatase activity;protein tyrosine phosphatase activity;protein binding;protein phosphatase binding;metal ion binding;phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity